Aarti Pharmalabs (AARTIPHARM) Share Price Falls 5.73% as Market Cap Stays at Rs 8,838.11 Cr
- September 9, 2026
- Posted by: Kunal Singla
- Category: News
Aarti Pharmalabs Share Price fell 5.73% to Rs 898.75, with the company’s market capitalisation at Rs 8,838.11 Cr. According to latest Univest figures, the move took the stock below its previous close of Rs 953.35 and placed today’s decline squarely in focus for Aarti Pharmalabs Share Price Today tracking. The stock traded between Rs 956 and Rs 897.05 in the current move, after opening at Rs 956. For readers following Aarti Pharmalabs Share Price News, the important point is simple: the price event is confirmed, but no company-specific catalyst is established. According to Univest data, that makes the latest Aarti Pharmalabs Share Price fall a numbers-led event that now shifts attention to valuation, sector context and peer comparison.
For investors scanning Aarti Pharmalabs Share Price Live, the combination of a Mid Cap label and an Rs 8,838.11 Cr market cap places the stock above the median market-cap size within its same industry benchmark set, while still well below several large peers. That keeps Aarti Pharmalabs Share Price relevant for stock analysis, especially when the day’s move is read alongside its P/E, P/B, ROE, ROCE and earnings metrics. In Univest’s market update format, the key question after a sharp share price fall is not only what moved today, but how the valuation stack compares with the Healthcare peer set and whether the company’s financial ratios justify that positioning.
Aarti Pharmalabs (AARTIPHARM) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 898.75 |
| Previous Close | Rs 953.35 |
| Today's Move | -Rs 54.60 (-5.73%) |
| Open | Rs 956 |
| High | Rs 956 |
| Low | Rs 897.05 |
| Market Capitalisation | Rs 8,838.11 crore |
| Market Cap Category | Mid Cap |
Aarti Pharmalabs Share Price Today reflects a clear intraday decline, with the stock last traded at Rs 898.75 versus a previous close of Rs 953.35. The change of Rs 54.60 equals a 5.73% fall, which means Aarti Pharmalabs Share Price moved lower from the start rather than recovering through the morning trade. It opened at Rs 956, matched the day’s high at Rs 956 and touched a low of Rs 897.05, so the current quote sits very near the lower end of the day’s range. That price action matters for Aarti Pharmalabs Share Price News because it shows a one-session decline in progress as of 08 October 2026 at 10:53:07 AM IST. The company’s Mid Cap classification and Rs 8,838.11 Cr market cap provide scale context before the discussion shifts to fundamental analysis.
From a market-news lens, Aarti Pharmalabs Share Price today is being read as a measurable price fall rather than a broad narrative event. According to latest Univest figures, the confirmed decline is the starting point for further analysis, not the conclusion. The next layer is valuation and financial quality.
Aarti Pharmalabs (AARTIPHARM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 8,838.11 crore |
| P/E Ratio | 40.56x |
| P/B Ratio | 3.95x |
| ROE | 8.5% |
| ROCE | 10.77% |
| EPS | Rs 23.51 |
| Book Value Per Share | Rs 241.54 |
| Dividend Yield | 0.37% |
Aarti Pharmalabs (AARTIPHARM) fundamental metrics show P/E 40.56x, P/B 3.95x, ROE 8.5%, ROCE 10.77%. These ratios show where the company stands today and are not a call to buy or sell.
Aarti Pharmalabs has a market capitalisation of Rs 8,838.11 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 40.56x, P/B at 3.95x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 8.5% and ROCE of 10.77%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 23.51, book value per share of Rs 241.54, dividend yield of 0.37%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.87x, median ROE of 11.61%, median ROCE of 13.46%. Together they describe the fundamental backdrop without implying a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 40.56x |
| Benchmark Median P/E | 31.87x |
| Benchmark Average P/E | 48.48x |
| Benchmark P/E Range | 3.58x to 708.87x |
| Company P/B Ratio | 3.95x |
| Benchmark Median P/B | 2.98x |
| Benchmark Average P/B | 4.31x |
| Company ROE | 8.5% |
| Benchmark Median ROE | 11.61% |
| Benchmark Average ROE | 10.59% |
| Company ROCE | 10.77% |
| Benchmark Median ROCE | 13.46% |
| Benchmark Average ROCE | 13.36% |
| Company Market Capitalisation | Rs 8,838.11 crore |
| Benchmark Median Market Cap | Rs 854.81 crore |
| Benchmark Average Market Cap | Rs 14,121.7 crore |
Aarti Pharmalabs (AARTIPHARM) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Aarti Pharmalabs (AARTIPHARM) has a P/E ratio of 40.56x, which is above the benchmark median of 31.87x, a difference of +27.27%. A P/E difference of this kind is a reference point rather than a recommendation.
Aarti Pharmalabs (AARTIPHARM) has a ROE of 8.5%, which is below the benchmark median of 11.61%, a difference of -26.79%. Aarti Pharmalabs (AARTIPHARM) has a ROCE of 10.77%, which is below the benchmark median of 13.46%, a difference of -19.99%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,32,120.23 | 35.37 | 4.95 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,53,389.76 | 86.95 | 14.4 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,81,739.76 | 82.14 | 19.96 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,15,710.44 | 25.51 | 4.27 | 19.69 | 21.39 |
| Laurus Labs | LAURUSLABS | 1,10,980.13 | 101.55 | 19.69 | 18.31 | 18.2 |
Aarti Pharmalabs (AARTIPHARM) has a P/E ratio of 40.56x compared with the displayed peer median of 82.14x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 8.5% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 10.77% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Aarti Pharmalabs (AARTIPHARM) has a market capitalisation of Rs 8,838.11 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Aarti Pharmalabs
- Aarti Pharmalabs Share Price fell 5.73% in the latest move, placing today’s decline at the centre of market attention.
- The stock traded near the lower end of its intraday range, with Rs 898.75 against a low of Rs 897.05.
- P/E of 40.56 is above the same-industry median, which keeps valuation in focus for Aarti Pharmalabs Share Price News.
- ROE of 8.5% and ROCE of 10.77% sit below the industry median, adding context to the move.
- Market cap of Rs 8,838.11 Cr and Mid Cap classification keep Aarti Pharmalabs Share Price relevant within Healthcare tracking.
About Aarti Pharmalabs
Aarti Pharmalabs operates in Healthcare, within the Pharmaceuticals & Drugs industry. The company’s market presence is reflected in its Rs 8,838.11 Cr market capitalisation and Mid Cap category. In practical terms, Aarti Pharmalabs Share Price reflects how investors value the business relative to its earnings, book value and profitability ratios. The company is positioned within a large and competitive pharma universe, where comparison with peers and the broader industry benchmark is central to understanding Aarti Pharmalabs Share Price Today and Aarti Pharmalabs Stock News. Its reported metrics suggest a business that is established enough to attract sector comparison, yet still distinct from the biggest names in the space.
Track Aarti Pharmalabs Share Price on Univest
Use Aarti Pharmalabs (AARTIPHARM) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
You can track Aarti Pharmalabs Share Price on Univest for live share price movement, key fundamental ratios, 52-week levels and market insights in one place. The same page also helps users follow Aarti Pharmalabs Share Price Today, Aarti Pharmalabs Share Price Update and Aarti Pharmalabs Latest News in a structured format. For readers comparing valuation and stock performance, Univest keeps the company snapshot aligned with the latest market context.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why did Aarti Pharmalabs Share Price fall today?
Ans. Aarti Pharmalabs Share Price fell 5.73% to Rs 898.75, but no company-specific catalyst is established in the verified figures. The move is confirmed through price action, previous close and intraday range, which is enough for a factual market update.
What is Aarti Pharmalabs Share Price Today?
Ans. Aarti Pharmalabs Share Price Today is Rs 898.75 as of 08 October 2026 at 10:53:07 AM IST. It is lower than the previous close of Rs 953.35 and traded between Rs 956 and Rs 897.05 during the move.
How much did Aarti Pharmalabs Share Price decline?
Ans. Aarti Pharmalabs Share Price declined by Rs 54.60, which equals 5.73%. That decline took the stock below its previous close and left it near the day’s low, making the price action important for short-term tracking.
What is the market capitalisation of Aarti Pharmalabs?
Ans. Aarti Pharmalabs has a market capitalisation of Rs 8,838.11 Cr and is classified as a Mid Cap company. That size places Aarti Pharmalabs Share Price above the industry median market-cap level within its same-industry benchmark group.
What do Aarti Pharmalabs valuation ratios show?
Ans. Aarti Pharmalabs trades at a P/E of 40.56 and a P/B of 3.95. Those ratios sit above the industry median on earnings multiples, so Aarti Pharmalabs Share Price remains valuation-sensitive within the Healthcare space.
How do ROE and ROCE look for Aarti Pharmalabs Share Price?
Ans. ROE is 8.5% and ROCE is 10.77%. Both are positive, but they sit below the same-industry median, which gives useful context when evaluating Aarti Pharmalabs Share Price against pharma peers.
What are the EPS and book value for Aarti Pharmalabs?
Ans. EPS is Rs 23.51 and book value is Rs 241.54 per share. EPS shows earnings attributable to each share, while book value shows accounting net worth behind each share, both relevant to Aarti Pharmalabs Share Price analysis.
Does Aarti Pharmalabs Share Price have a dividend yield?
Ans. Yes, the dividend yield is 0.37%. That figure is historical and current in nature, so it helps frame income context for Aarti Pharmalabs Share Price without implying any future payout pattern.
How does Aarti Pharmalabs compare with pharma peers?
Ans. Aarti Pharmalabs Share Price sits below several larger pharma peers on market cap and below leaders such as Lupin and Zydus on return ratios. Its P/E is also higher than some peers, which keeps relative valuation in focus.